Delta 9 Cannabis Inc.
DLTNF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $71 | $63 | $62 | $52 |
| % Growth | 12.4% | 1.5% | 19.7% | – |
| Cost of Goods Sold | $57 | $52 | $45 | $34 |
| Gross Profit | $14 | $11 | $17 | $18 |
| % Margin | 20.3% | 17.2% | 27.8% | 34.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $15 | $19 | $8 | $9 |
| SG&A Expenses | $16 | $20 | $19 | $16 |
| Sales & Mktg Exp. | $1 | $1 | $11 | $7 |
| Other Operating Expenses | $12 | $11 | $6 | $5 |
| Operating Expenses | $28 | $31 | $25 | $21 |
| Operating Income | -$13 | -$20 | -$8 | -$2 |
| % Margin | -19% | -32% | -12.3% | -4% |
| Other Income/Exp. Net | -$3 | -$8 | -$4 | -$3 |
| Pre-Tax Income | -$17 | -$28 | -$12 | -$5 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | -$18 | -$28 | -$11 | -$5 |
| % Margin | -24.6% | -44.5% | -17.9% | -10.5% |
| EPS | -0.1 | -0.22 | -0.11 | -0.061 |
| % Growth | 54.5% | -100% | -79.4% | – |
| EPS Diluted | -0.098 | -0.22 | -0.11 | -0.061 |
| Weighted Avg Shares Out | 175 | 126 | 103 | 89 |
| Weighted Avg Shares Out Dil | 179 | 126 | 103 | 89 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $7 | $7 | $4 | $3 |
| Depreciation & Amortization | $9 | $8 | $6 | $5 |
| EBITDA | -$1 | -$13 | -$1 | $3 |
| % Margin | -1.5% | -21.2% | -2.1% | 6.2% |